Increasing evidences show that PPARα [2, 10–12] or PPARγ [7, 8, 13] inhibits tumor progression, which acts as tumor suppressors, while some reports show that PPARα is associated with tumor progression [14–16]. The gene discussed is PPARG; the disease is neoplasm.